• IPR MDR report
  • CHI whitepapers
  • ProServices
  • Clinical Informatics News
  • MDX Report

Drug Diagnostic Co-Development:
Biomarkers in Personalized Medicine


Drug Diagnostic Co-Development

Life Science Podcast

The New Paradigm of Data Intensive/Data Rich Protein Informatics
Eugene Kolker, Ph.D., Chief Data Officer, Center for Developmental Therapeutics, Children’s Hospital Seattle
Interview with Mary Ann Brown Click here to download


Life Science Media Library

Educational DVDs are one of many assets available from the Cambridge Healthtech Institute Life Science Media Library.

View and order all our DVDs and CDs at healthtech.com/cddvd


CHI News Releases


11.03.14  Call for papers posted for Clinical Trial Oversight Summit June 1-4, 2015

10.23.14  Call for papers posted for World Preclinical Congress June 10-12, 2015


10.03.14 Final Agenda posted for Clinical Ops Executives (SCOPE) February 24-26, 2015


09.25.14 Final Agenda posted for Molecular Med Tri-Con February 15-20, 2015


09.25.14 Call for papers posted for Clinical Research Informatics World May 6-7, 2015


More Conference Updates...

Careers
Available Positions:
Why work for CHI?
INSIDE SALES, Conferences (attendee registrations)


Linkedin Twitter Xing Youtube

 


Conferences & Courses
PepTalk
January 19-23, 2015 | San Diego, CA
CHI’s PepTalk: The Protein Science Week is more than just a conference.

Life Science Media Library
Introduction to Adoptive T Cell Therapies DVD
May 5, 2014 |
Adoptive T cell therapy has the potential to increase antitumor immunity, enhance vaccine efficacy, and limit graft-versus-host disease (GVHD). Recent advances in protein engineering and molecular biology have increased the feasibility of using genetically engineered T cells to treat disease, leading to an influx of new discoveries and techniques. This course DVD will educate viewers on the basic rules of adoptive T cell therapies before delving into strategies for developing chimeric antigen receptors (CARs) and T cell receptors (TCRs).
Biological Therapeutic Products

Reports
Ocular Disorders: Rising Therapeutics, Technologies, and Devices
New to Insight Pharma Reports is: Ocular Disorders: Rising Therapeutics, Technologies, and Devices. This report covers several companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications.

Conferences & Courses
Molecular Medicine Tri Conference 2015
February 15-20, 2015 | San Francisco, CA
The 22nd International Molecular Medicine Tri-Conference is the industry’s Preeminent Event on Molecular Medicine, focusing on Drug Discovery, Genomics, Diagnostics and Information Technology.

Life Science Media Library
Next Generation Sequencing as a Diagnostics Platform
August 19, 2014 |
Next generation sequencing (NGS) has revolutionized genomics and is now on the verge of being widely adopted for medical sequencing. Until recently, comprehensive genetic testing for genetically heterogeneous diseases was limited by the high cost of traditional (Sanger) sequencing technology. NGS technologies have now completely eliminated this limit such that virtually any gene with a published association to the disease of interest can be tested. Whole exome or whole genome sequencing (WES/WGS) is the ultimate genetic test and many success stories provide a taste of its power. However, while the cost of generating high-quality whole genome sequence data is rapidly dropping, analysis of the enormous number of variants detected is still too complex to implement WGS/WES as a first line genetic test. Targeted NGS-based gene panels are typically an order of magnitude smaller than WES/WGS based testing but follow the same principles. Screening large sets of genes is particularly useful when the clinical diagnosis is uncertain as it eliminates the need for costly and lengthy cascade testing that has dominated genetic testing in the past. Drawbacks are significantly increased numbers of detected variants, which poses novel challenges for post-analytic data analyses. The focus of this short course is on understanding the use of NGS in clinical diagnosis, practical implementation of NGS in clinical laboratories and analysis of large data sets by using bioinformatics tools to parse and interpret data in relation to the clinical phenotype. The concluding presentation is dedicated to quality and standardization of NGS assays.

Conferences & Courses
Summit for Clinical Ops Executives (SCOPE)
February 24-26, 2015 | Orlando, FL
The 6th Annual SCOPE Summit, being held February 24-26, 2015 at the Hyatt Regency, Orlando, in Orlando, Florida, will offer three stimulating days of in-depth discussions in 12 different conferences focused on issues related to each aspect of clinical tri

Life Science Media Library
Impact of Affordable Care Act and the Sunshine Act on Industry
February 4, 2013 |
In this DVD, we will discuss the new "sunshine provisions" in the Patient Protection and Affordable Health Care Act ("PPACA") and its implications and effects on clinical trial operations. Key topics to be addressed: Insurance coverage and strategies to improve clinical trial enrollment What is the Sunshine Act and what are the company’s legal requirements? Opportunities in the Biosimilars FDA rules and changes in operations What are first steps and strategies to become compliant with state and federal laws? How can companies maintain flexibility in dealing with evolving legislation? What business processes and systems are involved? Implementation struggles: Centralization of all payments; FMV process and standardization and the effect Change Management with Study teams: The balance of compliance and challenges of patient recruitment, site shortage

Conferences & Courses
PepTalk
January 19-23, 2015 | San Diego, CA
CHI’s PepTalk: The Protein Science Week is more than just a conference.

Life Science Media Library
Operational Excellence in Bioprocessing
August 18, 2014 |
Ensuring quality in bioprocesses that complies with regulatory requirements and mitigates risk often results in very high bottom-line costs. Adopting best practices early in the development process and customizing these approaches to operational excellence from other highly competitive industries are currently taking place in biopharmaceutical production. This course provides both an overview of these approaches along with details about how they work, as well as case studies and data addressing how these innovations have been applied successfully in bioprocessing and the development of biopharmaceuticals. Appropriate regulatory guidance is also discussed.
Bioprocess & Manufacturing

Reports
Vaccines: The End of Illness
This report analyzes recent trends in medicinal chemistry and evaluates their significance for advancing R&D productivity. We consider technological modalities and market dynamics, with an emphasis on outsourcing and user views on the implications of current practices.

Conferences & Courses
High-Content Analysis
January 26-27, 2015 | San Diego, CA
CHI' s Twelfth Annual High-Content Analysis meeting, January 26-27, 2015 the premier event showcasing the latest advancements in HCA applications and technologies.

Life Science Media Library
Trends in Physical Properties of Drugs
April 22, 2014 |
The physical properties of drugs influence all aspects of their discovery, development, formulation, and administration. They are key to efficacy, effective assays, and in vivo delivery. This course will discuss latest trends and state-of-the art of prediction and measurement of key properties. Properties important for enhanced efficacy, delivery, and formulation pKa, tautomerism, crystallization, others Computational prediction: What works - what doesn’t Experimental best practices
Chemistry

Reports
Vaccines: The End of Illness
This report analyzes recent trends in medicinal chemistry and evaluates their significance for advancing R&D productivity. We consider technological modalities and market dynamics, with an emphasis on outsourcing and user views on the implications of current practices.

Conferences & Courses
Molecular Medicine Tri Conference 2015
February 16-18, 2015 | San Francisco, CA

Life Science Media Library
Clinical Trial Monitoring and Compliance
February 4, 2013 |
In this DVD, we will discuss the ever-changing role of the CRA and explore ways in which this relationship can be leveraged to maximize productivity with study sites. Key topics to be addressed: How to build and maintain the relationship between sponsor and site Ways to partner with your sites during different phases of clinical trials How to have an enrollment discussion with your site; define mutual goals and expectations How to ensure ROI on territory development activities
Clinical Trials & Translational Medicine

Reports
Vaccines: The End of Illness
This report analyzes recent trends in medicinal chemistry and evaluates their significance for advancing R&D productivity. We consider technological modalities and market dynamics, with an emphasis on outsourcing and user views on the implications of current practices.

Conferences & Courses

Life Science Media Library
Strategies for Protein Purification and Overcoming Aggregation
January 20, 2013 |
Together with input from Sarah Bondos from Texas A&M University, Mario Lebendiker of the Wolfson Centre for Applied Structural Biology at The Hebrew University of Jerusalem provides an indepth overview of protein purification with a particular focus on aggregation problems. This course reviews: common causes of protein aggregation during expression and purification, methods to detect the presence of aggregates, the types and properties of chemicals that, when added to buffers, may improve protein solubility, and methods to screen these additives to rapidly optimize the solubility of your protein.
Drug & Device Safety

Reports
Ocular Disorders: Rising Therapeutics, Technologies, and Devices
New to Insight Pharma Reports is: Ocular Disorders: Rising Therapeutics, Technologies, and Devices. This report covers several companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications.

Conferences & Courses
High-Content Analysis
January 26-27, 2015 | San Diego, CA
CHI' s Twelfth Annual High-Content Analysis meeting, January 26-27, 2015 the premier event showcasing the latest advancements in HCA applications and technologies.

Life Science Media Library
Trends in Physical Properties of Drugs
April 22, 2014 |
The physical properties of drugs influence all aspects of their discovery, development, formulation, and administration. They are key to efficacy, effective assays, and in vivo delivery. This course will discuss latest trends and state-of-the art of prediction and measurement of key properties. Properties important for enhanced efficacy, delivery, and formulation pKa, tautomerism, crystallization, others Computational prediction: What works - what doesn’t Experimental best practices
Drug Discovery & Development

Reports
Antibiotic Renaissance: Technology and Market Advances in the War against Drug-resistant Bacteria
Antibiotic Renaissance: Technology and Market Advances in the War against Drug-resistant Bacteria covers evolutionary growth of antibiotic resistant bacteria with a focus in research aspects, commercial aspects, market aspects, and trends in antibiotic resistance.

Conferences & Courses
Cancer Targets for Antibody Therapeutics
January 19-20, 2015 | San Diego, CA
Cancer Targets for Antibody Therapeutics explores new directions in the discovery of emerging and challenging targets in this space – and the steps that will be required in developing these into next generation therapeutics.

Life Science Media Library
Introduction to Adoptive T Cell Therapies DVD
May 5, 2014 |
Adoptive T cell therapy has the potential to increase antitumor immunity, enhance vaccine efficacy, and limit graft-versus-host disease (GVHD). Recent advances in protein engineering and molecular biology have increased the feasibility of using genetically engineered T cells to treat disease, leading to an influx of new discoveries and techniques. This course DVD will educate viewers on the basic rules of adoptive T cell therapies before delving into strategies for developing chimeric antigen receptors (CARs) and T cell receptors (TCRs).

Conferences & Courses
Companion Diagnostics
February 16-18, 2015 | San Francisco, CA
Companion diagnostics are rapidly emerging as key components in personalized medicine.

Life Science Media Library
Next Generation Sequencing
August 14, 2012 |
If you are confused by the evolving, rapidly changing, and dynamic nature of the Next Generation Sequencing market, then this is the course for you. This course will provide you with a comprehensive, clear outline of the various sequencing technologies currently available, their best suited applications, and which analysis strategies go with what applications in order to get the best answer from the data.

Conferences & Courses
Improving the Clinical Efficacy of Antibody Therapeutics
January 22-23, 2015 | San Diego, CA
At the beginning of 2013, according to one study, there were 350 monoclonal antibodies in development, and therapeutic mAbs have now moved beyond cancer and into a wide range of large disease indications.

Life Science Media Library
Clinical Genome Sequencing
June 11, 2012 |
The move to push genome sequencing into routine clinical practice requires arguably as much skill in navigating bureaucracy as mapping and interpreting base pairs. This short course provides practical information on crafting clinical sequencing and analysis pipeline strategies while navigating the route of CAP and CLIA certification by those who have sailed through these uncharted waters.
Healthcare

Reports
Ocular Disorders: Rising Therapeutics, Technologies, and Devices
New to Insight Pharma Reports is: Ocular Disorders: Rising Therapeutics, Technologies, and Devices. This report covers several companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications.

Conferences & Courses
Molecular Medicine Tri Conference 2015
February 15-20, 2015 | San Francisco, CA
The 22nd International Molecular Medicine Tri-Conference is the industry’s Preeminent Event on Molecular Medicine, focusing on Drug Discovery, Genomics, Diagnostics and Information Technology.

Life Science Media Library
IT Project Planning and Implementation
April 9, 2013 |
Key topics to be addressed: This session is designed to help the project team to understand and create a project plan for the delivery of the project to the portfolio; To provide assistance to project teams in the delivery of the Significant and high visible projects to portfolio where success is critical to both the team and the organization The success of any project depends on the planning activities especially delivery
IT & Informatics

Reports
Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks
This report analyzes recent trends in medicinal chemistry and evaluates their significance for advancing R&D productivity. We consider technological modalities and market dynamics, with an emphasis on outsourcing and user views on the implications of current practices.

Conferences & Courses
PepTalk
January 19-23, 2015 | San Diego, CA
CHI’s PepTalk: The Protein Science Week is more than just a conference.

Life Science Media Library
qPCR in Molecular Diagnostics
February 12, 2013 |
Quantitative real-time PCR is a valuable technology used for diagnostics of diseases such as cancer and infectious diseases, and for the detection of bacterial, fungal and viral pathogens. This course covers aspects of incorporating qPCR into standard molecular diagnosis including the challenges involved, an overview of the technology available, and next steps.

Conferences & Courses
Cancer Targets for Antibody Therapeutics
January 19-20, 2015 | San Diego, CA
Cancer Targets for Antibody Therapeutics explores new directions in the discovery of emerging and challenging targets in this space – and the steps that will be required in developing these into next generation therapeutics.

Life Science Media Library
Understanding EMT: Mechanisms and Metastasis to MET
February 20, 2012 |
Epethelial Mesenchymal Transition (EMT) plays a critical role in cancer cells, but understanding of its mechanisms is incomplete. EMT causes cells to develop increased motility, invasiveness, and greater resistance to apoptosis. These changes make the cells more like stem cells, allowing them to self renew. This course provides a framework of the underlying molecular mechanisms while addressing stem cells, and cancer progression, cMET and their activity as anti-metastasis agents, and the Mesenchymal-Epethelial Transition (MET) as an essential process for tumor re-initiation, colonization, and metastasis.

ABOUT CHI


CHI is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett Educational Services, Cambridge Meeting Planners and CHI’s Media Group, which includes news websites and e-newsletters including Bio-IT World and Clinical Informatics News.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related in commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.


CONFERENCES 


REPORTS 


BARNETT EDUCATIONAL SERVICES 


CONSULTING 


PUBLICATIONS & eNEWSLETTERS 


PROFESSIONAL SERVICES 


KNOWLEDGE FOUNDATION 


EXECUTIVE TEAM 


CAREERS